- Home
- J&J Innovative Medicine
J&J Innovative Medicine
The Johnson & Johnson under 40 to watch list: 6 young trailblazing scientists
These up-and-coming stars in oncology, immunology, anti-aging, vaccines and other areas of research are helping to change healthcare as we know it. And they’re just at the beginning of their brilliant careers.
6 Things We Now Know About Obesity
Over a third of Americans qualify as obese, but misconceptions abound as to what’s causing the global health epidemic. (Hint: It’s not just about diet and exercise.) We talked to obesity experts about the latest science-backed findings and current research underway.
7 Things We Now Know About Depression
It’s a complicated illness, with no exact cause, but there is still a lot we now understand about depression, thanks to the work of dedicated scientists. For World Mental Health Day, we look at the facts, common misconceptions and research that’s underway.
4 Ways Johnson & Johnson Has Helped Save the World’s Greatest Treasures
Get the behind-the-scenes scoop on how Janssen scientists helped preserve China’s famed Terracotta Warriors—now on display at the Franklin Institute—and other important historical artifacts.
The next frontier in cancer care: What you need to know about CAR-T cell therapy
It’s been in the news, but what does CAR-T really mean for patients? Immuno-oncology expert Iqbal Grewal, Ph.D., explains why the treatment has the potential to be a game changer for people with all types of cancer down the road.
4 amazing men and women at the forefront of HIV work
As the International AIDS Society Conference on HIV Science kicks off, we’re spotlighting researchers who’ve dedicated their life’s work to tackling the epidemic in groundbreaking ways.
Mitochondrial geneticist Douglas Wallace receives the 2017 Dr. Paul Janssen Award for biomedical research
Each year, Johnson & Johnson recognizes a scientist whose work has the potential to transform human health. We caught up with this year’s winner, who has dedicated his career to studying the powers of mitochondrial DNA.
Meet the Johnson & Johnson Scientist Who’s Helping to Fight Tropical Diseases in His Homeland
Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.
This Is Your Brain With Schizophrenia: How the Illness Manifests and What Researchers Are Doing to Help
Thanks to cutting-edge innovations in imaging, adherence and early intervention, mental health researchers are making crucial advances in the understanding and management of the complex condition. We delve into their work for Mental Health Awareness Month.
6 questions investors may have about Johnson & Johnson’s acquisition of Actelion
Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals, shares how the transaction will help expand the company’s portfolio of transformational therapies.